Noah Hillman M.D. IPOKRaTES Conference Guadalajaira, Mexico August 23, 2018
|
|
- Sydney Miles
- 5 years ago
- Views:
Transcription
1 Postnatal Steroids Use for Bronchopulmonary Dysplasia in = Noah Hillman M.D. IPOKRaTES Conference Guadalajaira, Mexico August 23, 2018
2 AAP Policy Statement This statement is intended for health care professionals caring for neonates and young infants. The objectives of this statement are to review the short- and long-term effects of systemic and inhaled postnatal corticosteroids for the prevention or treatment of evolving or established chronic lung disease and to make recommendations for the use of corticosteroids in infants with very low birth weight. The routine use of systemic dexamethasone for the prevention or treatment of chronic lung disease in infants with very low birth weight is not recommended. Pediatrics February 2002, VOLUME 109 / ISSUE 2
3 AAP Policy Statement The purpose of this revised statement is to review current information on the use of postnatal glucocorticoids to prevent or treat bronchopulmonary dysplasia in the preterm infant and to make updated recommendations regarding their use. High-dose dexamethasone (0.5 mg/kg per day) does not seem to confer additional therapeutic benefit over lower doses and is not recommended. Evidence is insufficient to make a recommendation regarding other glucocorticoid doses and preparations. The clinician must use clinical judgment when attempting to balance the potential adverse effects of glucocorticoid treatment with those of bronchopulmonary dysplasia. Pediatrics 2010;126:
4 Steroids at <7 days Decreases BPD Doyle LW et al. Cochrane Database Syst Rev Oct 24;10
5 Steroids at <7 days Decreases Death or BPD Doyle LW et al. Cochrane Database Syst Rev Oct 24;10
6 Steroids at <7 days Increases Cerebral Palsy Doyle LW et al. Cochrane Database Syst Rev Oct 24;10
7 Steroids at <7 days Increases Death or Abnormal Neurologic exam Doyle LW et al. Cochrane Database Syst Rev Oct 24;10
8 Table 1 Effects of postnatal corticosteroids on respiratory outcome, mortality and neurodevelopment BPD, bronchopulmonary dysplasia; CP, cerebral palsy. Outcome Time of initiation of corticosteroid course Early (<7 days) Moderately early Delayed BPD Death or BPD Failure to extubate Mortality at 28 days No effect Not applicable Mortality by discharge No effect No effect No effect Neurodevelopment Worse No different (?) CP, mortality Echinwald et al. Arch Dis Child Fetal Neonatal Ed Sep
9 Steroids at >7 days Decreases BPD Doyle LW et. al Cochrane Database Syst Rev Oct 24;10
10 Steroids at >7 days Decreases Death and BPD Doyle LW et. al Cochrane Database Syst Rev Oct 24;10
11 Steroids at >7 days No effect on Mental Disability Index < 2 SD Doyle LW et. al Cochrane Database Syst Rev Oct 24;10
12 Steroids at >7 days No effect on Death and Cerebral Palsy Doyle LW et. al Cochrane Database Syst Rev Oct 24;10
13 Table 1 Effects of postnatal corticosteroids on respiratory outcome, mortality and neurodevelopment BPD, bronchopulmonary dysplasia; CP, cerebral palsy. Outcome Time of initiation of corticosteroid course Early (<7 days) Moderately early Delayed BPD Death or BPD Failure to extubate Mortality at 28 days No effect Not applicable Mortality by discharge No effect No effect No effect Neurodevelopment Worse No different (?) CP, mortality Echinwald et al. Arch Dis Child Fetal Neonatal Ed Sep
14 Table 1 Effects of postnatal corticosteroids on respiratory outcome, mortality and neurodevelopment BPD, bronchopulmonary dysplasia; CP, cerebral palsy. Outcome Time of initiation of corticosteroid course Early (<7 days) Moderately early Delayed BPD Death or BPD Failure to extubate Mortality at 28 days No effect Not applicable Mortality by discharge No effect No effect No effect Neurodevelopment Worse No different (?) CP, mortality Echinwald et al. Arch Dis Child Fetal Neonatal Ed Sep
15 Meta-analysis of Steroid Trials and Neurologic Outcomes Doyle L et al Pediatrics March 2005
16 Gestational Age (Weeks) Birth weight Sex Race Postnatal Day Ventilator Type FiO 2
17 Dexamethasone Dosing? Depends on institution and beliefs 1) Higher dose dexamethasone (0.5 mg/kg/day) likely do not give an advantage over lower dose regimens 2) The DART study used lower dose of steroids (0.15 mg/kg/day for 3 days, 0.10 mg/kg/day for 3 days, 0.05 mg/kg/day for 2 days, and 0.02 mg/kg/day for 2 days) Increased extubation success but had little effect on BPD or mortality 3) At our institution, we do: 0.3 mg/kg/day for 3 days, 0.2 mg/kg/day for 3 days, 0.1 mg/kg/day for 3 days
18 Steroids to the Lung? - Instead of Systemic Early Inhaled Budesonide for the prevention of Bronchopulmonary Dysplasia Bassler et al. NEJM Oct 15, 2015 Randomized, placebo controlled trial of intubated infants Infants with a gestational age of 23 weeks 0 days to 27 weeks 6 days Any form of positive-pressure support at 12 hours Budesonide 400 μg every 12 hours in the first 14 days of life Then 200 μg every 12 hours from day 15 until the last dose of the study drug Study drugs were administered until infants no longer needed supplemental oxygen and positive-pressure support or reached a postmenstrual age of 32 weeks 0 days
19 Steroids to the Lung? - Instead of Systemic Early Inhaled Budesonide for the prevention of Bronchopulmonary Dysplasia Bassler et al. NEJM Oct 15, 2015
20 Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia N Engl J Med Jan 11;378(2):
21 Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia N Engl J Med Jan 11;378(2):
22 Shinwell ES et al. Pediatrics Dec;138(6). Inhaled Corticosteroid vs Placebo
23 Steroids to the Lung? - Instead of Systemic Intra-tracheal administration of Budesonide/Surfactant to prevent BPD Yeh et al. Am J Respir Crit Care Med Jan 1;193(1):86-95.
24 Intra-tracheal administration of Budesonide/Surfactant to prevent BPD Yeh et al. Am J Respir Crit Care Med Jan 1;193(1):86-95.
25 Surfactant plus Budesonide decreases lung and systemic inflammation over 24 hours of mechanical ventilation in preterm sheep T. Brett Kothe, Emily Royse, Matthew Kemp, Fabrizio Salomone, Gabrielle C Musk, Augusto Schmidt, Alan Jobe, Noah Hillman
26 Background Mechanical ventilation with large tidal volumes causes acute phase activation, lung inflammation, and airway injury in preterm sheep Can be decreased via several clinically relevant interventions: CPAP use during the stretch injury 3 Surfactant treatment 2 Antenatal corticosteroids 4 Additional therapies have proven elusive Dexamethasone or cortisol given prior to the injury do not suppress the injury 4 The incidence of BPD has remained the same, despite advances in the field of Neonatology 5
27 Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
28 Plasma Budesonide Levels Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
29 Physiologic Data OI = MAP x FiO2 / PaO2 VEI = 3800 / (ΔP x RR x PaCO2) Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
30 V o lu m e (m L /k g ) P r e s s u r e -V o lu m e C u r v e S u rfa c ta n t * * * * * * S u rfa c ta n t+ B u d P re s s u re (c m H 2 O )
31 Pro-inflammatory Cytokines in the lungs Decreased Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
32 Liver and Brain mrna Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
33 Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
34 Physiologic Data OI = MAP x FiO2 / PaO2 VEI = 3800 / (ΔP x RR x PaCO2) # = p < 0.05 vs Injury + Surf
35 Lung Parenchyma mrna # = p < 0.05 vs Injury + Surf
36 Brain and Liver mrna # = p < 0.05 vs Injury + Surf ; t = p < 0.05 vs Surf
37 Surfactant plus Budesonide for treatment of respiratory distress syndrome in very low birth weight preterm infants: a cohort comparison T. Brett Kothe, Farouk Sadiq, Howard Williams, Nikki Burleyson, Connie Anderson, Noah Hillman
38 Objective To evaluate the combination of Budesonide and surfactant for treatment of respiratory distress syndrome in very preterm infants.
39 Intervention On August 1 st, 2016 our NICU began combining Budesonide (0.25 mg/kg) with surfactant (Survanta 4 ml/kg) to all infants < 1250 grams who were intubated and normally would have received surfactant alone Intervention could be given in the delivery room, in either of our 2 NICUs, or by transport team with first surfactant administration Infants who received Budesonide with surfactant were compared to historical cohort (August 2013 to July 2016) Data was extracted from EPIC using Microsoft SQL server and verified through chart review Exclusion criteria included: Congenital anomalies or genetic disorders Gestational age less than 23 weeks 0 days
40 The Cohorts Historical Cohort: August 1 st, 2013 July 31 st, infants met inclusion criteria for study cohort Budesonide Cohort (as of April 20 th, 2018): 151 infants meeting the inclusion criteria have received Budesonide and surfactant 133 have reached 36 weeks corrected gestational age 128 have been discharged or died Data on the following slides are from discharged infants only
41 Demographic Data Historical Cohort Budesonide Cohort p Value n Gestational Age weeks weeks Birth Weight grams grams 5 Minute APGAR Male 53.1% 54.8% Caucasian 42.0% 37.7% Antenatal Corticosteroids 83.0% 83.6% Placental Inflammation 58.9% 51.8% Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
42 3 Day Data Historical Cohort Budesonide Cohort p Value n Dose of Surfactant Still Requiring Mechanical Ventilation 58.0% (167/288) 42.6% (63/148) < From online NICHD BPD Outcome Calculator, derived from work by Laughon et al in Prediction of Bronchopulmonary Dysplasia by Postnatal Age in Extremely Premature Infants. Am J Respir Crit Care Med Jun 15; 183(12): Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
43 7 Day Data Historical Cohort Budesonide Cohort p Value n Dose of Surfactant Still Requiring Mechanical Ventilation 48.2% 31.1% Risk for Moderate/Severe BPD or Death % 51.3% 0.02 Percent with Risk > 65% % 38.7% From online NICHD BPD Outcome Calculator, derived from work by Laughon et al in Prediction of Bronchopulmonary Dysplasia by Postnatal Age in Extremely Premature Infants. Am J Respir Crit Care Med Jun 15; 183(12): Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
44 36 Week Data Discharged Infants Historical Cohort Budesonide Cohort p Value n BPD 71.2%(187/263) 66.7% (92/138) 0.39 BPD Plus Death 74.2% 69.3% 0.19 Mild BPD 47.7% 47.0% 0.91 Moderate BPD 19.7% 14.5% 0.25 Severe BPD 3.8% 3.4% 1 Moderate/severe/death 31.8%(93/295) 23.8% (36/151) 0.1 Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
45 Discharge Data Historical Cohort Budesonide Cohort p Value n Postnatal Dexamethasone 52.9% 36.7% Required HFOV 44.4% 32.8% 0.03 Death 10.5% 8.6% 0.60 Length of Stay Days Days 0.03 Gestational Age at Discharge Discharged on Respiratory Support Weeks Weeks % 51.3% 0.82 Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
46 Secondary Outcomes Historical Cohort Budesonide Cohort p Value n Presence of PDA (By Echocardiogram) Medical Treatment (of Patients with PDA) Surgical Ligation (of Patients with PDA) Retinopathy of Prematurity > Stage 3 Retinopathy of Prematurity 63.1% 53.1% % 44.1% % 4.4% % 45.8% % 10.8% 1 Kothe TB, Hillman NH et al. Unpublished data Manuscript in preparation
47 Secondary Data No differences noted in multiple secondary outcomes, including: Necrotizing enterocolitis Spontaneous intestinal perforation Intraventricular hemorrhage Periventricular leukomalacia VP shunt/rickham reservoir placement Pneumothoraces Pulmonary interstitial emphysema Pulmonary hemorrhage Tracheostomy placement
48 Conclusions 1. There is a role for postnatal steroids in management of infants at risk for BPD 2. Early steroid (<7 days) are associated with decreased BPD but increased risk of Cerebral Palsy and poor neurologic outcome 3. Later steroids are associated with improved BPD without increased risk of Cerebral Palsy 4. Stratification of risk for BPD (using NICHD BPD Calculator) can be used to determine infants that will benefit most from steroids 5. Inhaled steroids can decrease BPD, but could have effect on mortality (No increase in meta-analysis of all trials) 6. Combining surfactant with budesonide a) Decreased BPD in a randomized trial of infants with severe RDS (Yeh et al) b) Decreased lung and brain inflammation in sheep c) Decreased mechanical ventilation and postnatal dexamethasone in cohort study, but did not decreased BPD
Hazards and Benefits of Postnatal Steroids. David J. Burchfield, MD Professor and Chief, Neonatology University of Florida
Hazards and Benefits of Postnatal Steroids David J. Burchfield, MD Professor and Chief, Neonatology University of Florida Disclosures I have no financial affiliations or relationships to disclose. I will
More informationROLE OF EARLY POSTNATAL DEXAMETHASONE IN RESPIRATORY DISTRESS SYNDROME
INDIAN PEDIATRICS VOLUME 35-FEBRUAKY 1998 ROLE OF EARLY POSTNATAL DEXAMETHASONE IN RESPIRATORY DISTRESS SYNDROME Kanya Mukhopadhyay, Praveen Kumar and Anil Narang From the Division of Neonatology, Department
More informationMcMASTER NICU INHALED STEROIDS FOR EVOLVING BPD (GA < 29 WEEKS)
McMASTER NICU INHALED STEROIDS FOR EVOLVING BPD (GA < 29 WEEKS) Developed by: Amit Mukerji, Samira Samiee-Zafarghandy, Jennifer Twiss, Ereny Bassilious, Elizabeth Vo, Shari Gray, Salhab el Helou on behalf
More informationPatent Ductus Arteriosus: Philosophy or Pathology?
Patent Ductus Arteriosus: Philosophy or Pathology? Disclosure Ray Sato, MD is a speaker for Prolacta Biosciences, Inc. This presentation will discuss off-label uses of acetaminophen and ibuprofen. RAY
More informationSWISS SOCIETY OF NEONATOLOGY. Spontaneous intestinal perforation or necrotizing enterocolitis?
SWISS SOCIETY OF NEONATOLOGY Spontaneous intestinal perforation or necrotizing enterocolitis? June 2004 2 Stocker M, Berger TM, Neonatal and Pediatric Intensive Care Unit, Children s Hospital of Lucerne,
More informationAdmission/Discharge Form for Infants Born in Please DO NOT mail or fax this form to the CPQCC Data Center. This form is for internal use ONLY.
Selection Criteria Admission/Discharge Form for Infants Born in 2016 To be eligible, you MUST answer YES to at least one of the possible criteria (A-C) A. 401 1500 grams o Yes B. GA range 22 0/7 31 6/7
More informationRescue Therapies in Neonatology. February 2014 Bill Walsh Monroe Carell Jr Children s Vanderbilt
Rescue Therapies in Neonatology February 2014 Bill Walsh Monroe Carell Jr Children s Vanderbilt Off Label Use-Disclaimer All discussion in this talk concerns off-label use of nitric oxide, steroids, and
More informationUpdate on mangement of patent ductus arteriosus in preterm infants. Dr. Trinh Thi Thu Ha
Update on mangement of patent ductus arteriosus in preterm infants Dr. Trinh Thi Thu Ha Outline 1. Overview of PDA 2. Timing of screening PDA? 3. When to treat PDA? Timing of ductal closure Prenatal
More informationAEROSURF Phase 2 Program Update Investor Conference Call
AEROSURF Phase 2 Program Update Investor Conference Call November 12, 2015 Forward Looking Statement To the extent that statements in this presentation are not strictly historical, including statements
More informationShort-Term Outcome Of Different Treatment Modalities Of Patent Ductus Arteriosus In Preterm Infants. Five Years Experiences In Qatar
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 7 Number 2 Short-Term Outcome Of Different Treatment Modalities Of Patent Ductus Arteriosus In Preterm Infants. Five Years Experiences In
More informationClinical Study Pulmonary Effects of Neonatal Hydrocortisone Treatment in Ventilator-Dependent Preterm Infants
International Pediatrics Volume 2011, Article ID 783893, 7 pages doi:10.1155/2011/783893 Clinical Study Pulmonary Effects of Neonatal Hydrocortisone Treatment in Ventilator-Dependent Preterm Infants Sandra
More informationRespiratory Management and Outcome of Preterm Infants
Respiratory Management and Outcome of Preterm Infants 6 th Annual Care Of The Sick Newborn Conference Shu Wu, MD. Department of Pediatrics Division of Neonatology University of Miami School of Medicine
More informationIs There a Treatment for BPD?
Is There a Treatment for BPD? Amir Kugelman, Pediatric Pulmonary Unit and Department of Neonatology Bnai Zion Medical Center, Rappaport Faculty of Medicine Haifa, Israel Conflict of Interest Our study
More informationKristi Watterberg, MD University of New Mexico
Kristi Watterberg, MD University of New Mexico Dr. Watterberg has no financial or other conflicts of interest to disclose She will be discussing studies of glucocorticoids in preterm infants History how
More informationName and title of the investigators responsible for conducting the research: Dr Anna Lavizzari, Dr Mariarosa Colnaghi
Protocol title: Heated, Humidified High-Flow Nasal Cannula vs Nasal CPAP for Respiratory Distress Syndrome of Prematurity. Protocol identifying number: Clinical Trials.gov NCT02570217 Name and title of
More informationOriginal Policy Date
MP 8.01.17 Inhaled Nitric Oxide Medical Policy Section Therapy Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed with literature search/12/2013 Return to Medical Policy Index
More informationPEDIATRIC NEWBORN MEDICINE CLINICAL PRACTICE GUIDELINES Pharmacologic Strategies for the Prevention of Bronchopulmonary Dysplasia
PEDIATRIC NEWBORN MEDICINE CLINICAL PRACTICE GUIDELINES Pharmacologic Strategies for the Prevention of Bronchopulmonary Dysplasia Clinical Practice Guideline: Pharmacologic Strategies for the Prevention
More informationUsefulness of DuoPAP in the treatment of very low birth weight preterm infants with neonatal respiratory distress syndrome
European Review for Medical and Pharmacological Sciences 2015; 19: 573-577 Usefulness of DuoPAP in the treatment of very low birth weight preterm infants with neonatal respiratory distress syndrome B.
More informationADMISSION/DISCHARGE FORM FOR INFANTS BORN IN 2019 DO NOT mail or fax this form to the CPQCC Data Center. This form is for internal use ONLY.
1 Any eligible inborn infant who dies in the delivery room or at any other location in your hospital within 12 hours after birth and prior to admission to the NICU is defined as a "Delivery Room Death."
More informationQuality Improvement Approaches to BPD. Jay P. Goldsmith, M.D. Tulane University New Orleans, Louisiana
Quality Improvement Approaches to BPD Jay P. Goldsmith, M.D. Tulane University New Orleans, Louisiana goldsmith.jay@gmail.com No conflicts of interest to declare There is nothing more dangerous to the
More informationResearch Article Timing of Caffeine Therapy and Neonatal Outcomes in Preterm Infants: A Retrospective Study
International Pediatrics Volume 2016, Article ID 9478204, 6 pages http://dx.doi.org/10.1155/2016/9478204 Research Article Timing of Caffeine Therapy and Neonatal Outcomes in Preterm Infants: A Retrospective
More informationRango de saturacion de oxigeno: Cual es la evidencia?
Rango de saturacion de oxigeno: Cual es la evidencia? Wally Carlo, M.D. University of Alabama at Birmingham Department of Pediatrics Division of Neonatology wcarlo@peds.uab.edu 1 2 Stevie Wonder 4 Objectives
More informationSWISS SOCIETY OF NEONATOLOGY. Supercarbia in an infant with meconium aspiration syndrome
SWISS SOCIETY OF NEONATOLOGY Supercarbia in an infant with meconium aspiration syndrome January 2006 2 Wilhelm C, Frey B, Department of Intensive Care and Neonatology, University Children s Hospital Zurich,
More informationKugelman A, Riskin A, Said W, Shoris I, Mor F, Bader D.
Heated, Humidified High-Flow Nasal Cannula (HHHFNC) vs. Nasal Intermittent Positive Pressure Ventilation (NIPPV) for the Primary Treatment of RDS, A Randomized, Controlled, Prospective, Pilot Study Kugelman
More informationPlanning Committee: Jeffery D. Horbar, MD, Madge E. Buus-Frank, RN, MS, APRN-BC, FAAN, Roger F. Soll, MD
Title of Program: What has Cochrane Neonatal Done For Babies? Speakers/Moderators: Roger F. Soll, MD Planning Committee: Jeffery D. Horbar, MD, Madge E. Buus-Frank, RN, MS, APRN-BC, FAAN, Roger F. Soll,
More informationPEDIATRIC PHARMACOTHERAPY
PEDIATRIC PHARMACOTHERAPY Volume 22 Number 12 December 2016 A The Role of Hydrocortisone in the Management of Bronchopulmonary Dysplasia Emily Monds, PharmD lthough the clinical landscape of bronchopulmonary
More informationBest Practices in Bronchopulmonary
Best Practices in Bronchopulmonary Dysplasia a (BPD) Prevention e Matthew M. Laughon, MD, MPH Professor of Pediatrics The University of North Carolina at Chapel Hill I receive support from the U.S. government
More informationAn Overview of Bronchopulmonary Dysplasia and Chronic Lung Disease in Infancy
An Overview of Bronchopulmonary Dysplasia and Chronic Lung Disease in Infancy Housekeeping: I have no financial disclosures Learning objectives: Develop an understanding of bronchopulmonary dysplasia (BPD)
More informationUSE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014
USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014 ino for Late Preterm and Term Infants with Severe PPHN Background:
More informationProphylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants(review)
Cochrane Database of Systematic Reviews Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants (Review) SubramaniamP,HoJJ,DavisPG Subramaniam
More informationHyaline membrane disease. By : Dr. Ch Sarishma Peadiatric Pg
Hyaline membrane disease By : Dr. Ch Sarishma Peadiatric Pg Also called Respiratory distress syndrome. It occurs primarily in premature infants; its incidence is inversely related to gestational age and
More informationReceived: Jun 15, 2013; Accepted: Nov 08, 2013; First Online Available: Jan 24, 2014
Original Article Iran J Pediatr Feb 2014; Vol 24 (No 1), Pp: 57-63 Management of Neonatal Respiratory Distress Syndrome Employing ACoRN Respiratory Sequence Protocol versus Early Nasal Continuous Positive
More informationProvide guidelines for the management of mechanical ventilation in infants <34 weeks gestation.
Page 1 of 5 PURPOSE: Provide guidelines for the management of mechanical ventilation in infants
More informationThe Basics. Editorial Team. Editorial Team 9/28/2017
Title of Program: What has Cochrane Neonatal Done For Babies? Speakers/Moderators: Roger F. Soll, MD Planning Committee: Jeffery D. Horbar, MD, Madge E. Buus-Frank, RN, MS, APRN-BC, FAAN, Roger F. Soll,
More informationEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Review)
Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Review) Halliday HL, Ehrenkranz RA, Doyle LW This is a reprint of a Cochrane review, prepared and maintained
More informationBronchopulmonary dysplasia: incidence and risk factors
Original article Arch Argent Pediatr 2017;115(5):476-482 / 476 Bronchopulmonary dysplasia: incidence and risk factors Pablo H. Brener Dik, M.D. a, Yeimy M. Niño Gualdron, M.D. a, María F. Galletti, M.D.
More information** SURFACTANT THERAPY**
** SURFACTANT THERAPY** Full Title of Guideline: Surfactant Therapy Author (include email and role): Stephen Wardle (V4) Reviewed by Dushyant Batra Consultant Neonatologist Division & Speciality: Division:
More informationNEONATAL NEWS Here s Some More Good Poop
NEONATALNEWS Here ssomemoregoodpoop WINTEREDITION2010 THISNEWSLETTERISPUBLISHEDPERIODICALLYBYTHENEONATOLOGISTSOF ASSOCIATESINNEWBORNMEDICINETOCONVEYNEWANDUPDATEDPOLICIES ANDGUIDELINESANDPROVIDEGENERALEDUCATIONTONICUCARETAKERSAT
More informationEvaluation of the Local Incidence and Determinants of Bronchopulmonary Dysplasia and Pulmonary Morbidity in Extremely Preterm Infants
Evaluation of the Local Incidence and Determinants of Bronchopulmonary Dysplasia and Pulmonary Morbidity in Extremely Preterm Infants by Amber Elise Reichert A thesis submitted in partial fulfilment of
More informationPATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT
PATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT Dr. Youssef Abou Zanouna, FRCPI, FACC Consultant Pediatric Cardiologist King Fahd Military Medical Complex Dhahran Introduction
More informationMinimizing Lung Damage During Respiratory Support
Minimizing Lung Damage During Respiratory Support University of Miami Jackson Memorial Medical Center Care of the Sick Newborn 15 Eduardo Bancalari MD University of Miami Miller School of Medicine Jackson
More informationUses 1,2,3 : Labeled: Prevention of respiratory distress syndrome in premature infants
Brand Name: Surfaxin Generic Name: lucinactant Manufacturer 1 : Discovery Laboratories, Inc. Drug Class 2,3 : Synthetic lung surfactant Uses 1,2,3 : Labeled: Prevention of respiratory distress syndrome
More informationBRONCHOPULMONARY DYSPLASIA
BRONCHOPULMONARY DYSPLASIA CHRONIC NEONATAL LUNG DISEASE (CLD) 2 2 nd BERLIN NEONATOLOGY SUMMER SCHOOL September 2014 3 Mt. Scopus 4 Ein Kerem 5 BRONCHOPULMONARY DYSPLASIA 1960: Ventilation of Neonates
More informationPostnatal Steroid (PNS) Administration: Rationale
Postnatal Steroid (PNS) Administration: Rationale Background: Postnatal steroid use has been subjected to intense scrutiny in recent years, the subject of several metaanalyses and most recently been the
More informationPneumothorax in preterm babies has been associated with an increased risk of intraventricular hemorrhage (IVH)
Identification of Pneumothorax in Very Preterm Infants Risha Bhatia, MB, MA, MRCPCH, Peter G. Davis, MD, FRACP, Lex W. Doyle, MD, FRACP, Connie Wong, RN, and Colin J. Morley, MD, FRACP, FRCPCH Objective
More informationChronic Lung Disease Of Prematurity. Dr Jo Harrison
Chronic Lung Disease Of Prematurity Dr Jo Harrison 9.9.14 Chronic Neonatal Lung Disease Bronchopulmonary dysplasia (BPD) first described in 1967 by Northway Defined as O 2 dependence at 28 days post birth
More informationObjectives. Apnea Definition and Pitfalls. Pathophysiology of Apnea. Apnea of Prematurity and hypoxemia episodes 5/18/2015
Apnea of Prematurity and hypoxemia episodes Deepak Jain MD Care of Sick Newborn Conference May 2015 Objectives Differentiating between apnea and hypoxemia episodes. Pathophysiology Diagnosis of apnea and
More informationSimulation 08: Cyanotic Preterm Infant in Respiratory Distress
Flow Chart Simulation 08: Cyanotic Preterm Infant in Respiratory Distress Opening Scenario Section 1 Type: DM As staff therapist assigned to a Level 2 NICU in a 250 bed rural medical center you are called
More informationReview Article Postnatal Corticosteroids for Prevention and Treatment of Chronic Lung Disease in the Preterm Newborn
International Journal of Pediatrics Volume 2012, Article ID 315642, 12 pages doi:10.1155/2012/315642 Review Article Postnatal Corticosteroids for Prevention and Treatment of Chronic Lung Disease in the
More information1
1 2 3 RIFAI 5 6 Dublin cohort, retrospective review. Milrinone was commenced at an initial dose of 0.50 μg/kg/minute up to 0.75 μg/kg/minute and was continued depending on clinical response. No loading
More informationTehran University of Medical Sciences, Tehran, Iran. Received: 22 May 2013; Received in revised form: 12 Sep. 2013; Accepted: 17 Sep.
ORIGINAL ARTICLE Comparison of INSURE Method with Conventional Mechanical Ventilation after Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: Therapeutic Challenge Fatemeh
More informationNasal CPAP in Neonatology: We Can Do Better
Nasal CPAP in Neonatology: We Can Do Better COI Disclosure I do not have any conflict of interest, nor will I be discussing any off-label product use. This class has no commercial support or sponsorship,
More informationIncidence of Bronchopulmonary Dysplasia in Korea
ORIGINAL ARTICLE Pediatrics http://dx.doi.org/1.3346/jkms.12.27.8.914 J Korean Med Sci 12; 27: 914-921 Incidence of Bronchopulmonary Dysplasia in Korea Chang Won Choi 1,2, Beyong Il Kim 1,2, Ee-Kyung Kim
More informationCOMPARISON OF THE EFFICIENCY OF CAFFEINE VERSUS AMINOPHYLLINE FOR THE TREATMENT OF APNOEA OF PREMATURITY
CASE STUDIES COMPARISON OF THE EFFICIENCY OF CAFFEINE VERSUS AMINOPHYLLINE FOR THE TREATMENT OF APNOEA OF PREMATURITY Gabriela Ildiko Zonda 1, Andreea Avasiloaiei 1, Mihaela Moscalu 2, Maria Stamatin 1
More informationResearch Roundtable Summary
Research Roundtable Summary 10 TENTH in a Series of Seminars on MCHB-funded Research Projects Early Cortisol Deficiency and Bronchopulmonary Dysplasia October 18, 1995 Parklawn Building Potomac Conference
More informationSurfactant Administration
Approved by: Surfactant Administration Gail Cameron Senior Director Operations, Maternal, Neonatal & Child Health Programs Dr. Paul Byrne Medical Director, Neonatology Neonatal Policy & Procedures Manual
More informationProphylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neonates
Iran Red Crescent Med J. 2014 August; 16(8): e12559. Published online 2014 August 5. DOI: 10.5812/ircmj.12559 Research Article Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm
More informationBubble CPAP for Respiratory Distress Syndrome in Preterm Infants
R E S E A R C H P A P E R Bubble CPAP for Respiratory Distress Syndrome in Preterm Infants JAGDISH KOTI*, SRINIVAS MURKI, PRAMOD GADDAM, ANUPAMA REDDY AND M DASARADHA RAMI REDDY From Fernandez Hospital
More informationDisclosures. Learning Objectives. Mechanical Ventilation of Infants with Severe BPD: An Interdisciplinary Approach 3/10/2017
Mechanical Ventilation of Infants with Severe BPD: An Interdisciplinary Approach Steven H. Abman, MD Professor, Department of Pediatrics Director, Pediatric Heart Lung Center University of Colorado School
More informationWith wider acceptance of the early use of
Weaning of nasal CPAP in preterm infants: who, when and how? a systematic review of literature Shaili Amatya, Deepa Rastogi, Alok Bhutada, Shantanu Rastogi New York, USA Background: There is increased
More informationPostnatal Corticosteroids for the Prevention and Treatment of Chronic Lung Disease in Preterm Infants
Postnatal Corticosteroids for the Prevention and Treatment of Chronic Lung Disease in Preterm Infants Clinical trial evidence for the effectiveness of corticosteroids in the prevention of CLD is strong
More informationMEDICAL POLICY I. POLICY POLICY TITLE POLICY NUMBER INHALED NITRIC OXIDE MP-4.021
Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): January 28, 2014 Effective Date: April 1, 2014 I. POLICY Inhaled nitric oxide may be considered medically necessary as
More informationBack to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
More informationSURFACTANT UPDATE. George Mandy, M.D. Nationwide Children s Hospital The Ohio State University
SURFACTANT UPDATE George Mandy, M.D. Nationwide Children s Hospital The Ohio State University Surfactant Update Objectives History Meta-analysis of surfactant therapy New synthetic surfactant Genetic disorders
More informationInhaled dry salt micro particles in the treatment of bronchopulmonary dysplasia: a five case series report
SIGNA VITAE 2017; 13(2): 85-89 Inhaled dry salt micro particles in the treatment of bronchopulmonary dysplasia: a five case series report NINE LUMINITA 2, CATALIN G CIRSTOVEANU 1, ALEXANDRA I ISTRATE BARZAN
More informationPredicting Mortality and Intestinal Failure in Neonates with Surgical Necrotizing Enterocolitis
Predicting Mortality and Intestinal Failure in Neonates with Surgical Necrotizing Enterocolitis Darshna Bhatt MHA DO, Curtis Travers MPH, Ravi M. Patel MD MSc, Julia Shinnick MD, Kelly Arps MD, Sarah Keene,
More informationSAMPLE. V.12.1 Special Report: Very Low Birthweight Neonates. I. Introduction
I. Introduction V.12.1 Special Report: Very Low Birthweight Neonates The delivery of a very low birth weight infant continues to present many challenges to families and health care providers in spite of
More informationBenefits of Caffeine Citrate: Neurodevelopmental Outcomes of ELBW Infants
St. Catherine University SOPHIA Master of Arts in Nursing Theses Nursing 12-2011 Benefits of Caffeine Citrate: Neurodevelopmental Outcomes of ELBW Infants Teri Johnson St. Catherine University Follow this
More informationBy: Armend Lokku Supervisor: Dr. Lucia Mirea. Maternal-Infant Care Research Center, Mount Sinai Hospital
By: Armend Lokku Supervisor: Dr. Lucia Mirea Maternal-Infant Care Research Center, Mount Sinai Hospital Background My practicum placement was at the Maternal-Infant Care Research Center (MiCare) at Mount
More informationAn Update on Caffeine Therapy
An Update on Caffeine Therapy Emory University School of Medicine Atlanta, GA Wally Carlo, MD University of Alabama at Birmingham Department of Pediatrics Division of Neonatology wcarlo@peds.uab.edu Objectives
More informationComparing the Efficacy of High and Low Doses of Vitamin A in Prevention of Bronchopulmonary Dysplasia
http:// ijp.mums.ac.ir Original Article (Pages: 1919-1925) Comparing the Efficacy of High and Low Doses of Vitamin A in Prevention of Bronchopulmonary Dysplasia Majid Mahallei 1, *Manizheh Mostafa Gharehbaghi
More informationFANNP 28TH NATIONAL NNP SYMPOSIUM: CLINICAL UPDATE AND REVIEW OCTOBER 17-21, 2017
Pulse Oximetry in the Delivery Room: Principles and Practice GS2 3 Jonathan P. Mintzer, MD, FAAP Assistant Professor of Pediatrics Stony Brook Children s Hospital, Division of Neonatal-Perinatal Medicine,
More informationAvailable online at ScienceDirect. journal homepage:
Pediatrics and Neonatology (2016) 57, 19e26 Available online at www.sciencedirect.com ScienceDirect journal homepage: http://www.pediatr-neonatol.com ORIGINAL ARTICLE Bovine Surfactant Replacement Therapy
More informationThe Effectiveness of Surfactant Replacement Therapy for Preterm Infants with Respiratory Dis~ress Syndrome
The Effectiveness of Surfactant Replacement Therapy for Preterm Infants with Respiratory Dis~ress Syndrome W L Lim, MRCP, C T Lim, FRCP, J K Chye, FRACP, Department of Paediatrics, U nive.rsity of Malaya,
More informationDevelopmental outcomes of preterm infants with bronchopulmonary dysplasiaassociated pulmonary hypertension at months of corrected age
Choi et al. BMC Pediatrics (2019) 19:26 https://doi.org/10.1186/s12887-019-1400-3 RESEARCH ARTICLE Open Access Developmental outcomes of preterm infants with bronchopulmonary dysplasiaassociated pulmonary
More informationOverview of Bronchopulmonary Dysplasia
Overview of Bronchopulmonary Dysplasia Terrence W. Carver, Jr., M.D. Children s Mercy Hospitals and Clinics Medical Director of Respiratory Care and Pulmonary Medicine Associate Professor of Pediatrics
More informationA Multi center Randomized Trial of Laparotomy vs. Drainage
A Multi center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants with Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18
More informationDr. AM MAALIM KPA 2018
Dr. AM MAALIM KPA 2018 Journey Towards Lung protection Goals of lung protection Strategies Summary Conclusion Before 1960: Oxygen; impact assessed clinically. The 1960s:President JFK, Ventilators mortality;
More informationNon Invasive Ventilation In Preterm Infants. Manuel Sanchez Luna Hospital General Universitario Gregorio Marañón Complutense University Madrid
Non Invasive Ventilation In Preterm Infants Manuel Sanchez Luna Hospital General Universitario Gregorio Marañón Complutense University Madrid Summary Noninvasive ventilation begings in the delivery room
More informationMedically Fragile Children (Chapter 2)
Medically Fragile Children (Chapter 2) Birth to three programs classify children with delays as those who have either established risk or are at risk Established risk infants are those with Genetic disorders
More informationThe Turkish Journal of Pediatrics 2014; 56:
The Turkish Journal of Pediatrics 2014; 56: 232-237 Original INSURE method (INtubation-SURfactant-Extubation) in early and late premature neonates with respiratory distress: factors affecting the outcome
More informationECMO FOR PEDIATRIC RESPIRATORY FAILURE. Novik Budiwardhana * PCICU Harapan Kita National Cardiovascular Center Jakarta
ECMO FOR PEDIATRIC RESPIRATORY FAILURE Novik Budiwardhana * PCICU Harapan Kita National Cardiovascular Center Jakarta Introduction Case D 8 month old baby with severe ARDS with fungal sepsis. He was on
More information12th International Scientific Conference «Science and Society» London, November 2017 MEDICINE
MEDICINE Li T.A., Maltabarova N.A. SEVERE BRONCHOPULMONARY DYSPLASIA AND PEDIATRIC ACUTE RESPIRATORY DISTRESS SYNDROME. RESEMBLANCE AND CONTRAST Li Tatyana Anatolyevna, PhD doctoral student, Department
More informationMirhadi Mussavi, 1 Keyvan Mirnia, 1 and Khairollah Asadollahi 2,* Iran J Pediatr October; 26(5):e5743. doi: /ijp.5743.
Iran J Pediatr. 2016 October; 26(5):e5743. Published online 2016 July 25. doi: 10.5812/ijp.5743. Research Article Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact)
More informationWhat s new in neonatal resuscitation?
What s new in neonatal resuscitation? Anup Katheria, M.D. Director, Neonatal Research Institute Sharp Mary Birch Hospital for Women & Newborns Disclosures I have no financial Disclosures. Overview Delivery
More informationEffects of permissive hypercapnia on pulmonary and neurodevelopmental sequelae in extremely low birth weight infants: a meta analysis
DOI 10.1186/s40064-016-2437-5 REVIEW Open Access Effects of permissive hypercapnia on pulmonary and neurodevelopmental sequelae in extremely low birth weight infants: a meta analysis Jianglin Ma 1 and
More informationEarly nasal intermittent positive pressure ventilation(nippv) versus early nasal continuous positive airway pressure(ncpap) for preterm
Cochrane Database of Systematic Reviews Early nasal intermittent positive pressure ventilation(nippv) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants(review) LemyreB,LaughonM,BoseC,DavisPG
More informationO) or to bi-level NCPAP (group B; n=20, lower CPAP level=4.5 cm H 2
1 NICU, Children s Hospital, Via Castelvetro, Milan, Italy 2 Laboratory, V.Buzzi Children s Hospital ICP, Milan, Italy 3 Department of Statistics, Catholic University, Milan, Italy Correspondence to Gianluca
More informationRandomized study of nasal continuous positive airway pressure in the preterm infant with respiratory distress syndrome
Acta Pñdiatr 92: 1±6. 2003 Randomized study of nasal continuous positive airway pressure in the preterm infant with respiratory distress syndrome J Tooley and M Dyke Department of Paediatrics, Norfolk
More informationLate(œ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants(review)
Cochrane Database of Systematic Reviews Late(œ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants (Review) Doyle LW, Cheong JL, Ehrenkranz RA, Halliday
More informationNeurodevelopmental outcomes of premature infants with bronchopulmonary dysplasia
Acta Biomed 2014; Vol. 85, Supplement 1: 30-34 Mattioli 1885 Original article Neurodevelopmental outcomes of premature infants with bronchopulmonary dysplasia Neonatal Unit, Department of Paediatrics,
More information9/15/2017. Disclosures. Heated High Flow Nasal Cannula: Hot Air or Optimal Noninvasive Support? Objectives. Aerogen Pharma
Heated High Flow Nasal Cannula: Hot Air or Optimal Noninvasive Support? Rob DiBlasi RRT-NPS, FAARC Program Manager Research/QI, Respiratory Therapy Principle Investigator, Seattle Children s Research Institute
More informationCPAP failure in preterm infants: incidence, predictors and consequences
CPAP failure in preterm infants: incidence, predictors and consequences SUPPLEMENTAL TEXT METHODS Study setting The Royal Hobart Hospital has an 11-bed combined Neonatal and Paediatric Intensive Care Unit
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/46692 holds various files of this Leiden University dissertation Author: Zanten, Henriëtte van Title: Oxygen titration and compliance with targeting oxygen
More informationPAEDIATRIC RESPIRATORY FAILURE. Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre
PAEDIATRIC RESPIRATORY FAILURE Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre Outline of lecture Bronchiolitis Bronchopulmonary dysplasia Asthma ARDS Bronchiolitis
More informationNon-invasive ventilatory strategies, such as
R E S E A R C H P A P E R Heated Humidified High Flow Nasal Cannula versus Nasal Continuous Positive Airway Pressure as Primary Mode of Respiratory Support for Respiratory Distress in Preterm Infants DEEPARAJ
More informationAdjunct Therapies for Pediatric ARDS: Where are the Data?
Adjunct Therapies for Pediatric ARDS: Where are the Data? Alexandre T. Rotta, MD, FCCM Professor of Pediatrics, Linsalata Family Endowed Chair in Pediatric Critical Care and Emergency Medicine Rainbow
More informationNIH Public Access Author Manuscript Am J Perinatol. Author manuscript; available in PMC 2010 November 1.
NIH Public Access Author Manuscript Published in final edited form as: Am J Perinatol. 2010 May ; 27(5): 425 429. doi:10.1055/s-0029-1243371. Safety and Effectiveness of Indomethacin versus Ibuprofen for
More informationNASDAQ: WINT. April 2016
NASDAQ: WINT April 2016 Forward Looking Statement To the extent that statements in this presentation are not strictly historical, including statements about the Company s business strategy, outlook, objectives,
More information